Bicalutamide capsules

Bicalutamide capsules
Product Description

50mg daily: Combination with luteinizing hormone releasing hormone (LHRH) analogs or surgical orchiectomy for the treatment of advanced prostatic carcinoma.

150mg daily: For the treatment of patients with locally advanced prostate cancer without distant metastasis, who are unsuitable or unwilling to undergo surgical castration or other medical procedures.

Shanxi Zhendong Pharmaceutical Co,ltd.

  • Country/Region:
    China
  • On CPHI since:
    2017
Specifications
  • Details
    50mg daily: Combination with luteinizing hormone releasing hormone (LHRH) analogs or surgical orchiectomy for the treatment of advanced prostatic carcinoma.

    150mg daily: For the treatment of patients with locally advanced prostate cancer without distant metastasis, who are unsuitable or unwilling to undergo surgical castration or other medical procedures.

  • Model
    50mg
  • Measured In
    milligram

Shanxi Zhendong Pharmaceutical Co,ltd.

  • Country/Region:
    China
  • On CPHI since:
    2017

More Products from Shanxi Zhendong Pharmaceutical Co,ltd. (2)

  • Abiraterone acetate tablets

    Product Abiraterone acetate tablets

    Abiraterone works by reducing androgen production in the body. Androgens are male hormones that can promote tumor growth in the prostate gland.


    Abiraterone is used together with steroid medication (prednisone or methylprednisolone) to treat prostate cancer that has spread to o...
  • Enzalutamide Soft Capsules

    Product Enzalutamide Soft Capsules

    Suitable for metastatic resistance to prostate cancer (CRPC). After the failure of androgen deprivation of therapy (ADT), Enzalutamide can delay the progress of the disease by inhibiting the inhibitors of therogen receptor signaling pathway and improve the quality of life of patients.